LumaCina - Bridgewest Perth Pharma
Armand Amin is an experienced business leader currently serving as the Chief Business Officer at LumaCina - Bridgewest Perth Pharma since January 2024. Previously, Armand held the position of Advisory Manager at ZS from January 2020 to January 2024 and served as Sr. Manager of Market Insights at Seagen for a brief period in 2019. Armand's career also includes a tenure as Sr. Manager of Strategic Planning at BioDuro from January 2013 to January 2018. Armand holds an MBA from the University of California, Berkeley, Haas School of Business, and a Master of Public Health in Health Policy & Management from the University of California, Berkeley.
This person is not in any teams
This person is not in any offices
LumaCina - Bridgewest Perth Pharma
Empowering Health Worldwide: Welcome to Lumacina, Your Global Hub for Cutting-Edge Sterile Injectable Solutions! As proud distributors of a dynamic portfolio we ensure top-notch quality. Our futuristic R&D is propelling a wave of innovation, set to revolutionize regulated and semi-regulated markets across the globe. From multi-dose vials to blow-fill-seal presentations and cytotoxic products, we're the pioneers of diverse dosage forms. Bridgewest Group Fueling Innovation: Lumacina, a Luminary in Bridgewest Perth Pharma, a Proud Entity of Bridgewest Group. Unleashing Potential with NovaCina and LumaCina, We're Transforming the Future of Healthcare."